Home Photos Surgery Types Cosmetic Surgeons Surgery Prices Surgery Risks Plastic Surgery News

Sanofi pulls obesity drug application in U.S. (Reuters)

Reuters - Sanofi-Aventis SA is withdrawing its application to sell obesity drug rimonabant — its biggest new drug hope — in the United States, the French drugmaker said on Friday.

More: continued here





You can respond, or trackback from your own site.


Related News

  • Sanofi withdraws anti-obesity drug in US (AFP)
  • Panel rejects new weight-loss drug (AP)
  • Sanofi obesity drug faces tough EU safety review (Reuters)
  • Key US drug panel rejects Sanofi's obesity pill (AFP)
  • Sanofi-Aventis withdraws anti-obesity drug from sale in Europe (AFP)
  • Controversial obesity drug gets UK okay (Reuters)
  • Akorn Files New Drug Application With FDA For Topical Ocular OSN SuperSite Subscription
  • Anti-Obesity Drug Might Also Lower Cholesterol (HealthDay)
  • Panel rejects Sanofi obesity drug (Reuters)
  • Obesity drug has little effect on heart in teens (Reuters)


    • Leave a Reply
    Cosmetic Surgery Procedure.com | Cosmetic Surgery Types | Find a Cosmetic Surgeon | Cosmetic Surgery Prices | Cosmetic Surgery Risks | Resources | Contact Us